Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Sensitized Renal Allograft Candidates
NCT00722722Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2008
- Primary completion
- Apr 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in kidney transplantation, sponsored by Mayo Clinic. Started Jun 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00722722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722722.